Dilated cardiomyopathy differential diagnosis: Difference between revisions

Jump to navigation Jump to search
Line 128: Line 128:
|[[Hypertrophic cardiomyopathy|Hypertrophic Cardiomyopathy]]
|[[Hypertrophic cardiomyopathy|Hypertrophic Cardiomyopathy]]
|
|
* [[Familial]]
* [[Gene mutation]]
* [[Hypertension]]
* Thyroid disease
* Diabetes
* Obesity
|
|
|
* [[Chest pain]]
* [[Congestive heart failure]] symptoms
* [[Dizziness]]
* [[Dyspnea]]
* [[Exercise intolerance]]
* [[Syncope]]
* [[Fatigue]]
|The diagnosis is based on
 
* Electrocardiogram
* Echocardiography according to ACCF/[[American Heart Association|AHA]] Guideline for the Diagnosis and Treatment of [[Hypertrophic cardiomyopathy|Hypertrophic Cardiomyopathy]]
|-
|-
|[[Noncompaction cardiomyopathy|Left ventricular noncompaction]]
|[[Noncompaction cardiomyopathy|Left ventricular noncompaction]]

Revision as of 06:51, 9 December 2019

Dilated cardiomyopathy Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Classification

Causes

Differentiating Dilated cardiomyopathy from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Dilated cardiomyopathy differential diagnosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Dilated cardiomyopathy differential diagnosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Dilated cardiomyopathy differential diagnosis

CDC on Dilated cardiomyopathy differential diagnosis

Dilated cardiomyopathy differential diagnosis in the news

Blogs on Dilated cardiomyopathy differential diagnosis

Directions to Hospitals Treating Dilated cardiomyopathy

Risk calculators and risk factors for Dilated cardiomyopathy differential diagnosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Abdelrahman Ibrahim Abushouk, MD[2]

Overview

Dilated cardiomyopathy should be differentiated from other causes of cardiac dysfunction

Differentiating Beriberi from other Diseases

Dilated cardiomyopathy should be differentiated from other causes of cardiac dysfunction

Disorders Etiology Clinical Presentation Laboratory Findings
Acute Coronary Syndrome
  • Echocardiogram: ST segment and T wave changes, pathological Q waves.
  • Elevated blood troponin levels (after 6 hours of attack onset)
  • Elevated blood CK-MB levels
Acute Pericarditis
  • Echocardiogram: Slight ST segment elevation in several leads & diffuse T wave inversion
  • CBC: Increased WBCs count
  • Modest increase in CK-MB
  • Elevated CRP levels.
Amphetamine/Cocaine

Cardiomyopathy

  • Illicit drug use
  • Drug and toxicology screen
  • Elevated serum CK (rhabdomyolysis)
  • Impaired electrolytes levels
Arrhythmogenic right ventricular

cardiomyopathy (ARVC/D)

Diagnostic criteria are based on:
Wet Beriberi
  • Inadequate thiamine intake (rice-based foods, alcoholism, and malnutrition)
  • Increased thiamine loss (protracted vomiting)
  • Inadequate absorption (after bariatric surgery or genetic mutation)
Cardiac Tamponade
  • Acute tamponade: Cardiogenic shock, hypotension, cold extremities, peripheral cyanosis, and decreased urine output.
  • Subacute tamponade: Peripheral edema with gradual progression to the aforementioned clinical picture.
  • Echocardiography to score the European Society of Cardiology (ESC) Working Group on Myocardial and Pericardial Diseases
  • Increased serum CK-MB and troponin
  • Cause-related investigations as serum inflammatory markers, diagnostic pericardiocentesis, and Gallium 67 imaging.
Hyperthyroidism
  • Elevated T3 and T4 hormones
  • TSH: Reduced in 1ry and Elevated in 2ry hyperthyroidism.
  • Thyroid stimulating antibodies: Elevated only in Grave's disease
Hypertrophic Cardiomyopathy The diagnosis is based on
Left ventricular noncompaction
Myocarditis
Restrictive Cardiomyopathy

References


Template:WH Template:WS